Asset 2123.png

Asylia

News

Asylia Diagnostics BV is presenting results

Thrilled to share that Asylia Diagnostics BV is presenting our exciting scientific results for metastatic melanoma and immunotherapy response prediction at ESMO - European Society for Medical Oncology, IMMUNO-ONCOLOGY congress. Join us in Geneva at 8-11 December.

EIT Health Catapult

On Wednesday December 1st at 1pm, our CEO Andrey Khmelevskiy will represent Asylia Diagnostics during the EIT Health Catapult semifinals in the Biotech category.

We are truly humbled to be part of an incredible cohort, together with 13 other companies: AddaxBiosciences, APLEX Bio, ARTHEx Biotech, Bioadhesive Ophthalmics, Enantis, Finnadvance, myNEO - Personalised platform for cancer, OmicEra Diagnostics, Onena Medicines, Limula, Renovos Biologics Limited, SideROS and SolasCure.

Curing cancer with the power of AI

Our CEO Andrey Khmelevskiy had an interview with Sofie Van Poucke for Invest in Flanders . They discussed why what we do in Asylia Diagnostics BV is important for clinicians and cancer patients worldwide and why we felt that Flanders is the perfect place for us to grow the biotech company. We are immensely grateful to Flanders biotech community and people who all helped us to learn about the unique Flanders ecosystem. This ecosystem is not only incredibly professional but also so welcoming to newcomers like us.

International cancer cluster showcase

After #ICCS2020, we are pleased to announce that Asylia Diagnostics BV Andrey Khmelevskiy has recently received an EIT Health and Team Bedrijfstrajecten - VLAIO non-dilutive grant of 628K to further support the development of its innovative diagnostics technology!

Also selected to join the prestigious MassBio MassCONNECT program, where they will have access to mentoring & business support from industry experts.

Asylia Diagnostics BV developed a platform intended to provide safer immunotherapy for cancer patients. CEO Andrey Khmelevskiy explains how the platform works, and how the Belgian ecosystem and imec.istart offered them the fertile ground that allowed their startup to blossom.

New ventures get the stage

We will be presenting our Asylia Diagnostics BV pitch at flanders.bio and VIB 6th edition of State of the Union - an event for the announcement of new developments and initiatives in the Flemish life sciences cluster.